ACTHERA was a Swiss biotech company founded in 2019, in liquidation since 2024. The team was developing a therapeutic platform based on a unique type of liposomes for the targeted delivery of drugs. Due to lack of funding, the decision was taken early 2024 to liquidate the company.
Company Details
- Founded
- -
- Address
- Basel, Basel, Ch
- Industry
- Biotechnology
- Website
- actheratx.com
- HQ
- Basel, Basel
Acthera Therapeutics Ltd. Questions
Acthera Therapeutics Ltd.'s website is actheratx.com
Acthera Therapeutics Ltd.'s LinkedIn profile is https://ch.linkedin.com/company/actheratherapeutics
Acthera Therapeutics Ltd.'s industry is
Biotechnology
Acthera Therapeutics Ltd.'s top competitors are
Alentis Therapeutics,
Cellestia Biotech,
Aurealis Therapeutics,
Anaveon Ag,
Versameb Ag,
Araris Biotech Ag,
Saverna Therapeutics Ag,
Altamira Therapeutics,
Forx Therapeutics,
Canvirex.
Acthera Therapeutics Ltd.'s categories are Biotechnology
Acthera Therapeutics Ltd.'s founding year is 2019
